For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
NPS clinical audits for GPsNPS clinical audits for GPs
Our clinical audits are free quality improvement activities that help GPs to review their current prescribing practice for patients with certain conditions compared to current best practice guidelines.
- More about clinical audits
- More about Clinical e-Audit
- Clinical e-audit virtual tour (video)
- Qualify for CPD points, as well as PIP incentives for your practice
- Past audits (participation is no longer available, but you can access and use the resources pack to review your practice).
Current audits
| Title | Date |
|---|---|
|
Clinical e-Audit: CVD risk and lipid-modifying therapy
This software is designed for use on Microsoft Windows XP, Vista or Windows 7. |
Complete before 30 April 2012 to be recognised in the QPI year (1 May to 30 April) in which it is completed. |
|
Clinical e-Audit: Management of hypertension
This software is designed for use on Microsoft Windows XP, Vista or Windows 7. |
Complete before 30 April 2012 to be recognised in the QPI year (1 May to 30 April) in which it is completed. |
|
Clinical e-Audit: Review of proton pump inhibitor (PPI) prescribing This software is designed for use on Microsoft Windows XP, Vista or Windows 7.
|
Complete before 30 April 2012 to be recognised in the QPI year (1 May to 30 April) in which it is completed. |
|
Clinical e-Audit: Optimising management of type 2 diabetes 
This software is designed for use on Microsoft Windows XP, Vista or Windows 7. |
Complete before 30 April 2012 to be recognised in the QPI year (1 May to 30 April) in which it is completed. |
Past audits
| Title | Date |
|---|---|
|
Clinical audit: Safe and effective use of antipsychotic therapy |
|
|
Clinical audit: Reducing risk of osteoporotic fractures and falls
|
|
|
Review of opioid prescribing in chronic pain
|
2010 – Closed |
|
Management of stable COPD and smoking cessation
|
2010 – Closed |
|
Use of benzodiazepines, zolpidem and zopiclone in insomnia
|
|
| Managing specific respiratory tract infections |
2009 – Closed |
| Review of proton pump inhibitor prescribing |
2009 – Closed |
| Antiplatelet and anticoagulant therapy in stroke prevention |
2009 – Closed |
| 2008 – Closed | |
| Using inhaled corticosteroids and long-acting beta2 agonists |
2008 – Closed
|
|
2008 – Closed |
|
|
2007 – Closed |
|
|
2007 – Closed |
|
|
2007 – Closed |
|
|
2006 – Closed |
|
|
2006 – Closed |
|
|
2006 – Closed |
|
|
2005 – Closed |
|
|
2005 – Closed |
|
|
2005 – Closed |
|
|
2004 – Closed |
|
|
2004 – Closed |
|
|
2004 – Closed |
|
|
2003 – Closed |
|
|
2003 – Closed |
|
|
2003 – Closed |
|
|
2002 – Closed |
|
|
2002 – Closed |
|
|
2001 – Closed |
Date published: 2011-06-24 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
